BCL2 antibody (B-Cell CLL/lymphoma 2) (AA 41-54) (PE)

Details for Product anti-BCL2 Antibody No. ABIN2662398, Supplier: Log in to see
Antigen
  • Bcl-2
  • PPP1R50
  • bcl-2
  • AW986256
  • C430015F12Rik
  • D630044D05Rik
  • D830018M01Rik
  • BCL-2
  • Bcl2
  • B-cell CLL/lymphoma 2
  • B cell leukemia/lymphoma 2
  • B-cell leukemia/lymphoma 2
  • B-cell leukemia/lymphoma 2-like
  • B-cell CLL/lymphoma 2 protein
  • BCL2
  • Bcl2
  • LOC100224888
  • bcl2
  • LOC100359045
  • BCL-2
Alternatives
anti-Human BCL2 antibody for Cell Culture
Epitope
AA 41-54
164
73
64
59
41
33
25
25
24
21
18
15
15
15
13
13
13
11
9
8
6
6
5
5
5
5
5
4
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
1001
253
211
54
28
22
18
18
5
4
4
3
2
2
2
2
Host
Mouse
549
517
19
6
2
2
2
Clonality (Clone)
Monoclonal ()
Conjugate
This BCL2 antibody is conjugated to PE
49
48
42
37
24
23
22
15
15
13
13
13
13
13
13
13
12
12
12
7
7
7
6
6
6
6
6
6
6
2
2
1
1
1
1
1
1
1
1
1
1
1
Application
Flow Cytometry (FACS)
791
374
361
309
307
297
228
191
170
81
40
15
14
13
12
11
9
4
3
2
1
1
1
1
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen AA 41-54 of human bcl-2 oncoprotein
Clone 100
Isotype IgG1
Purification The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
Alternative Name Bcl-2 (BCL2 Antibody Abstract)
Background Bcl-2 is a conserved anti-apoptotic protein that plays important roles in normal immunity. It forms homodimers or heterodimers with other Bcl-2 family members. This protein regulates apoptosis through controlling mitochondrial fusion and fission. Phosphorylation of Bcl-2 has been shown to enhance activity to allow response to extracellular growth-factor-mediated signals. Bcl-2 is also regulated by IRES, miR-15a, miR-16-1 and RNA-BP nucleolin. Chromosome 18q21.3 translocation and overexpression of Bcl-2 is frequently observed in follicular lymphomas and some diffuse large B-cell lymphomas.
Research Area Cancer, Apoptosis/Necrosis
Pathways MAPK Signaling, PI3K-Akt Signaling, Apoptosis, Caspase Cascade in Apoptosis, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Skeletal Muscle Fiber Development, Autophagy, Smooth Muscle Cell Migration, Negative Regulation of intrinsic apoptotic Signaling
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Buffer Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Protect from prolonged exposure to light. Do not freeze.
Storage 4 °C
Storage Comment The antibody solution should be stored undiluted between 2°C and 8°C.
Supplier Images
Flow Cytometry (FACS) image for anti-BCL2 antibody (B-Cell CLL/lymphoma 2) (AA 41-54) (PE) (ABIN2662398) anti-B-Cell CLL/lymphoma 2 (BCL2) (AA 41-54) antibody (PE)
Background publications Lin, Medeiros: "The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma." in: Current hematologic malignancy reports, Vol. 8, Issue 3, pp. 243-52, 2013 (PubMed).

Kelly, Strasser: "The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy." in: Cell death and differentiation, Vol. 18, Issue 9, pp. 1414-24, 2011 (PubMed).

Tomita: "BCL2 and MYC dual-hit lymphoma/leukemia." in: Journal of clinical and experimental hematopathology : JCEH, Vol. 51, Issue 1, pp. 7-12, 2011 (PubMed).

Rolland, Conradt: "New role of the BCL2 family of proteins in the regulation of mitochondrial dynamics." in: Current opinion in cell biology, Vol. 22, Issue 6, pp. 852-8, 2010 (PubMed).

Willimott, Wagner: "Post-transcriptional and post-translational regulation of Bcl2." in: Biochemical Society transactions, Vol. 38, Issue 6, pp. 1571-5, 2010 (PubMed).

Pezzella, Turley, Kuzu, Tungekar, Dunnill, Pierce, Harris, Gatter, Mason: "bcl-2 protein in non-small-cell lung carcinoma." in: The New England journal of medicine, Vol. 329, Issue 10, pp. 690-4, 1993 (PubMed).

Pezzella, Tse, Cordell, Pulford, Gatter, Mason: "Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation." in: The American journal of pathology, Vol. 137, Issue 2, pp. 225-32, 1990 (PubMed).